Literature DB >> 23329495

Production of CD4⁺ and CD8⁺ T cell hybridomas.

David H Canaday1.   

Abstract

T cell hybridomas are very useful tools to investigate antigen presenting cell (APC) function. They were developed based on the fusion technology that led to monoclonal antibody section. Antigen-specific primary T cells are generated and fused to an immortal thymoma line. Unfused thymoma cells are eliminated by engineered metabolic selection. Antigen-specific hybridomas are identified and may be characterized in detail. Primary T cells are preferable for studies of the regulatory mechanisms intrinsic to T cells, but for study of antigen presentation T cell hybridomas have advantages over primary T cell clones, including their relative uniformity, stability over time, and ready availability in large numbers for extensive antigen presentation experiments.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329495      PMCID: PMC4552323          DOI: 10.1007/978-1-62703-218-6_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Generation of class I MHC-restricted T-T hybridomas.

Authors:  K L Rock; L Rothstein; S Gamble
Journal:  J Immunol       Date:  1990-08-01       Impact factor: 5.422

3.  Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.

Authors:  G Zhong; C Reis e Sousa; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

4.  A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay.

Authors:  S A Ahmed; R M Gogal; J E Walsh
Journal:  J Immunol Methods       Date:  1994-04-15       Impact factor: 2.303

5.  Preserved MHC class II antigen processing in monocytes from HIV-infected individuals.

Authors:  Laila Woc-Colburn; Lavinia Smultea; Lakshmi Ramachandra; David H Canaday
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

6.  Hock immunization: a humane alternative to mouse footpad injections.

Authors:  T Kamala
Journal:  J Immunol Methods       Date:  2007-08-28       Impact factor: 2.303

7.  Rapid MHC-II antigen presentation of HIV type 1 by human dendritic cells.

Authors:  Leola Jones; David McDonald; David H Canaday
Journal:  AIDS Res Hum Retroviruses       Date:  2007-06       Impact factor: 2.205

8.  HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene.

Authors:  Y C Kong; L C Lomo; R W Motte; A A Giraldo; J Baisch; G Strauss; G J Hämmerling; C S David
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

9.  Inhibition of MHC class II-restricted T cell response by Lyt-2 alloantigen.

Authors:  O Kanagawa; R Maki
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

10.  Reactivity of V beta 17a+ CD8+ T cell hybrids. Analysis using a new CD8+ T cell fusion partner.

Authors:  H G Burgert; J White; H U Weltzien; P Marrack; J W Kappler
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

View more
  4 in total

1.  CD1b-autoreactive T cells contribute to hyperlipidemia-induced skin inflammation in mice.

Authors:  Sreya Bagchi; Ying He; Hong Zhang; Liang Cao; Ildiko Van Rhijn; D Branch Moody; Johann E Gudjonsson; Chyung-Ru Wang
Journal:  J Clin Invest       Date:  2017-05-02       Impact factor: 14.808

2.  CD1b-autoreactive T cells recognize phospholipid antigens and contribute to antitumor immunity against a CD1b+ T cell lymphoma.

Authors:  Sreya Bagchi; Sha Li; Chyung-Ru Wang
Journal:  Oncoimmunology       Date:  2016-07-22       Impact factor: 8.110

3.  Multiplex T Cell Stimulation Assay Utilizing a T Cell Activation Reporter-Based Detection System.

Authors:  Sarah E Mann; Zhicheng Zhou; Laurie G Landry; Amanda M Anderson; Aimon K Alkanani; Jeremy Fischer; Mark Peakman; Roberto Mallone; Kristen Campbell; Aaron W Michels; Maki Nakayama
Journal:  Front Immunol       Date:  2020-04-09       Impact factor: 7.561

4.  Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs.

Authors:  Mark Yarmarkovich; Quinlen F Marshall; John M Warrington; Rasika Premaratne; Alvin Farrel; David Groff; Wei Li; Moreno di Marco; Erin Runbeck; Hau Truong; Jugmohit S Toor; Sarvind Tripathi; Son Nguyen; Helena Shen; Tiffany Noel; Nicole L Church; Amber Weiner; Nathan Kendsersky; Dan Martinez; Rebecca Weisberg; Molly Christie; Laurence Eisenlohr; Kristopher R Bosse; Dimiter S Dimitrov; Stefan Stevanovic; Nikolaos G Sgourakis; Ben R Kiefel; John M Maris
Journal:  Nature       Date:  2021-11-03       Impact factor: 49.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.